PMC5217977_01
Changes in (A) A1C and (B) triglycerides in Patients 1-3. A1C, glycated hemoglobin.
ccrep-9-2016-123f1.jpg
PMC5217977_03_ccrep-9-2016-123f1.jpg
f1-ccrep-9-2016-123
A1C was reduced from 11.8% to 6.7% (Fig. 1).
PMC5217977_02
Changes in (A) A1C and (B) triglycerides in Patients 1-3. A1C, glycated hemoglobin.
ccrep-9-2016-123f1.jpg
PMC5217977_03_ccrep-9-2016-123f1.jpg
f1-ccrep-9-2016-123
A1C was reduced from 11.8% to 6.7% (Fig. 1).
PMC5217977_03
Changes in (A) A1C and (B) triglycerides in Patients 1-3. A1C, glycated hemoglobin.
ccrep-9-2016-123f1.jpg
PMC5217977_03_ccrep-9-2016-123f1.jpg
f1-ccrep-9-2016-123
A1C was reduced from 11.8% to 6.7% (Fig. 1).